Prevent Chemotherapy-Induced Nausea and Vomiting: Information at emend.com
Merck

Despite treatment with a 5-HT3 receptor antagonist and a corticosteroid,
nausea & vomiting remains a serious problem.

Results from clinical trials show patients still suffer from chemotherapy-induced nausea and vomiting (CINV).

  1. Reference:1.Warr DG, Hesketh PJ, Gralla RJ, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol. 2005;23(12):2822–2830.

Important Safety Information

EMEND and EMEND for Injection, in combination with other antiemetic agents, are indicated in adults for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, including high-dose cisplatin.

EMEND and EMEND for Injection have not been studied for treatment of established nausea and vomiting. Chronic continuous administration of EMEND or EMEND for Injection is not recommended.

Selected Important Safety Information

Before prescribing EMEND or EMEND for Injection, please read the Prescribing Information. The Patient Information also is available.

The information on this site is intended for health care professionals in the United States and is not intended for the general public.

I am a health care professional

I am not a health care professional